Efficient gene transfer to airway epithelium using recombinant Sendai virus
- 1 September 2000
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 18 (9) , 970-973
- https://doi.org/10.1038/79463
Abstract
Clinical studies of gene therapy for cystic fibrosis (CF) suggest that the key problem is the efficiency of gene transfer to the airway epithelium. The availability of relevant vector receptors, the transient contact time between vector and epithelium, and the barrier function of airway mucus contribute significantly to this problem. We have recently developed recombinant Sendai virus (SeV) as a new gene transfer agent. Here we show that SeV produces efficient transfection throughout the respiratory tract of both mice and ferrets in vivo, as well as in freshly obtained human nasal epithelial cells in vitro. Gene transfer efficiency was several log orders greater than with cationic liposomes or adenovirus. Even very brief contact time was sufficient to produce this effect, and levels of expression were not significantly reduced by airway mucus. Our investigations suggest that SeV may provide a useful new vector for airway gene transfer.This publication has 23 references indexed in Scilit:
- The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epitheliumGene Therapy, 1999
- ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivoGene Therapy, 1997
- HVJ (Sendai virus)-cationic liposomes: a novel and potentially effective liposome-mediated technique for gene transfer to the airway epitheliumGene Therapy, 1997
- Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosisGene Therapy, 1997
- Detailed Analysis of Structures and Formulations of Cationic Lipids for Efficient Gene Transfer to the LungHuman Gene Therapy, 1996
- Agonistmstimulated free calcium in subcellular compartmentsCell Calcium, 1996
- Modification of Nasal Epithelial Potential Differences of Individuals with Cystic Fibrosis Consequent to Local Administration of a Normal CFTR cDNA Adenovirus Gene Transfer VectorHuman Gene Therapy, 1995
- Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosisPublished by Elsevier ,1993
- Submucosal glands are the predominant site of CFTR expression in the human bronchusNature Genetics, 1992
- Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosisNature Genetics, 1992